Chemomab Therapeutics Ltd - Company Profile
Powered by 
All the sales intelligence you need on Chemomab Therapeutics Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Chemomab Therapeutics Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Chemomab Therapeutics Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Chemomab Therapeutics Ltd (Chemomab), formerly Anchiano Therapeutics Ltd, develops targeted therapy for the treatment of several types of cancers. Chemomab’s focused R&D, manufacturing abilities, and lead product candidate CM-101are its key strengths even as its history of losses continues to be an area of concern. Growing market for cancer treatments, positive outlook of healthcare market in the US, and patent grants of the company provide opportunity for the company. However, government regulations, reliance on third party manufacturers, and increasing competitive pressures could adversely affect the outcome of the company's products.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer